These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3141815)

  • 1. Genentech loses appeal against Wellcome.
    McGourty C
    Nature; 1988 Nov; 336(6194):4. PubMed ID: 3141815
    [No Abstract]   [Full Text] [Related]  

  • 2. TPA patent battle rages in United Kingdom.
    Johnston K
    Nature; 1987 Jun 11-17; 327(6122):450. PubMed ID: 3108671
    [No Abstract]   [Full Text] [Related]  

  • 3. Problems over TPA patent for Genentech in Japan.
    Swinbanks D
    Nature; 1988 Jun; 333(6174):587. PubMed ID: 3131683
    [No Abstract]   [Full Text] [Related]  

  • 4. Biotechnology patents. Genentech wins round two.
    Gershon D
    Nature; 1990 Apr; 344(6268):692. PubMed ID: 2109830
    [No Abstract]   [Full Text] [Related]  

  • 5. Wellcome versus Genentech result.
    Johnston K
    Nature; 1987 Jul 16-22; 328(6127):189. PubMed ID: 3110626
    [No Abstract]   [Full Text] [Related]  

  • 6. Genentech patent.
    Nature; 1988 Sep; 335(6186):105. PubMed ID: 3137476
    [No Abstract]   [Full Text] [Related]  

  • 7. Biotechnology: Wellcome drops TPA.
    Gershon D
    Nature; 1990 May; 345(6272):194. PubMed ID: 2110295
    [No Abstract]   [Full Text] [Related]  

  • 8. Genentech falls at the last fence in race to market heart drug.
    Anderson A
    Nature; 1987 Jun 11-17; 327(6122):450. PubMed ID: 3108670
    [No Abstract]   [Full Text] [Related]  

  • 9. Genentech gets patent protection for tissue plasminogen activator.
    Ezzell C
    Nature; 1988 Jun; 333(6176):790. PubMed ID: 3133565
    [No Abstract]   [Full Text] [Related]  

  • 10. Biotechnology. All systems go in Britain.
    Newmark P
    Nature; 1986 Mar 13-19; 320(6058):100. PubMed ID: 2419766
    [No Abstract]   [Full Text] [Related]  

  • 11. Boehringer Mannheim's new clot buster.
    Nat Biotechnol; 1997 Feb; 15(2):114. PubMed ID: 9035121
    [No Abstract]   [Full Text] [Related]  

  • 12. Companies vie over new heart drug.
    Sun M
    Science; 1987 Jul; 237(4811):120-2. PubMed ID: 3110949
    [No Abstract]   [Full Text] [Related]  

  • 13. Claims on tissue plasminogen activator.
    Crespi RS
    Nature; 1989 Jan; 337(6205):317-8. PubMed ID: 2492089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genentech stops making TPA.
    Wagner M
    Mod Healthc; 1988 Oct; 18(43):5. PubMed ID: 10325205
    [No Abstract]   [Full Text] [Related]  

  • 15. Comment on US geographic distribution of recombinant tissue plasminogen activator use by hospitals for acute ischemic stroke.
    Albright K; Martin-Schild S; Morales M; Grotta J
    Stroke; 2010 Apr; 41(4):e189; author reply e190. PubMed ID: 20185785
    [No Abstract]   [Full Text] [Related]  

  • 16. Alteplase (rtPA) patent case.
    Brahams D
    Lancet; 1988 Nov; 2(8622):1263. PubMed ID: 2904002
    [No Abstract]   [Full Text] [Related]  

  • 17. Laboratory and clinical experience with recombinant plasminogen activator.
    Builder SE; Grossbard E
    Prog Clin Biol Res; 1986; 211():303-13. PubMed ID: 3083430
    [No Abstract]   [Full Text] [Related]  

  • 18. Genentech loses another patent dispute in court.
    Ezzell C
    Nature; 1987 Jul 30-Aug 5; 328(6129):372. PubMed ID: 3112577
    [No Abstract]   [Full Text] [Related]  

  • 19. [Recombinant DNA technology in thrombolytic therapy: tissue-type plasminogen activator].
    Mazza P
    Boll Chim Farm; 1991 Mar; 130(3):105-7. PubMed ID: 1909876
    [No Abstract]   [Full Text] [Related]  

  • 20. Soluble expression of active recombinant human tissue plasminogen activator derivative (K2S) in Escherichia coli.
    Luo XG; Tian WJ; Ni M; Jing XL; Lv LH; Wang N; Jiang Y; Zhang TC
    Pharm Biol; 2011 Jun; 49(6):653-7. PubMed ID: 21554008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.